Global Nuclear Radiation Therapeutic Drugs Supply, Demand and Key Producers, 2023-2029
The global Nuclear Radiation Therapeutic Drugs
market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Nuclear Radiation Therapeutic Drugs consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
This report studies the global Nuclear Radiation Therapeutic Drugs
production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Radiation Therapeutic Drugs
, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Radiation Therapeutic Drugs
that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Radiation Therapeutic Drugs
total production and demand, 2018-2029, (Units)
Global Nuclear Radiation Therapeutic Drugs
total production value, 2018-2029, (USD Million)
Global Nuclear Radiation Therapeutic Drugs
production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Nuclear Radiation Therapeutic Drugs
consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Nuclear Radiation Therapeutic Drugs
domestic production, consumption, key domestic manufacturers and share
Global Nuclear Radiation Therapeutic Drugs
production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Nuclear Radiation Therapeutic Drugs
production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Nuclear Radiation Therapeutic Drugs
production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units)
This reports profiles key players in the global Nuclear Radiation Therapeutic Drugs
market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution and Ciaeriar, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Radiation Therapeutic Drugs
market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nuclear Radiation Therapeutic Drugs
Market, By Region:
Market, Segmentation by Type
Market, Segmentation by Application
1. How big is the global Nuclear Radiation Therapeutic Drugs
market?
2. What is the demand of the global Nuclear Radiation Therapeutic Drugs
market?
3. What is the year over year growth of the global Nuclear Radiation Therapeutic Drugs
market?
4. What is the production and production value of the global Nuclear Radiation Therapeutic Drugs
market?
5. Who are the key producers in the global Nuclear Radiation Therapeutic Drugs
market?
6. What are the growth factors driving the market demand?
market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Nuclear Radiation Therapeutic Drugs consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
This report studies the global Nuclear Radiation Therapeutic Drugs
production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Radiation Therapeutic Drugs
, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Radiation Therapeutic Drugs
that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Radiation Therapeutic Drugs
total production and demand, 2018-2029, (Units)
Global Nuclear Radiation Therapeutic Drugs
total production value, 2018-2029, (USD Million)
Global Nuclear Radiation Therapeutic Drugs
production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Nuclear Radiation Therapeutic Drugs
consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Nuclear Radiation Therapeutic Drugs
domestic production, consumption, key domestic manufacturers and share
Global Nuclear Radiation Therapeutic Drugs
production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Nuclear Radiation Therapeutic Drugs
production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Nuclear Radiation Therapeutic Drugs
production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units)
This reports profiles key players in the global Nuclear Radiation Therapeutic Drugs
market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution and Ciaeriar, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Radiation Therapeutic Drugs
market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nuclear Radiation Therapeutic Drugs
Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market, Segmentation by Type
- Diagnostic
- Therapeutic
Market, Segmentation by Application
- Oncology
- Thyroid
- Cardiology
- Others
- Nihon Medi-Physics Co.,Ltd.
- Curium Pharma
- Cardinal Health
- Bayer Global
- GE Healthcare
- Mallinckrodt Pharmaceuticals
- Bracco Group
- Advanced Molecular-imaging Solution
- Ciaeriar
- Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
1. How big is the global Nuclear Radiation Therapeutic Drugs
market?
2. What is the demand of the global Nuclear Radiation Therapeutic Drugs
market?
3. What is the year over year growth of the global Nuclear Radiation Therapeutic Drugs
market?
4. What is the production and production value of the global Nuclear Radiation Therapeutic Drugs
market?
5. Who are the key producers in the global Nuclear Radiation Therapeutic Drugs
market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Nuclear Radiation Therapeutic Drugs
Introduction
1.2 World Nuclear Radiation Therapeutic Drugs
Supply & Forecast
1.2.1 World Nuclear Radiation Therapeutic Drugs
Production Value (2018 & 2022 & 2029)
1.2.2 World Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.2.3 World Nuclear Radiation Therapeutic Drugs
Pricing Trends (2018-2029)
1.3 World Nuclear Radiation Therapeutic Drugs
Production by Region (Based on Production Site)
1.3.1 World Nuclear Radiation Therapeutic Drugs
Production Value by Region (2018-2029)
1.3.2 World Nuclear Radiation Therapeutic Drugs
Production by Region (2018-2029)
1.3.3 World Nuclear Radiation Therapeutic Drugs
Average Price by Region (2018-2029)
1.3.4 North America Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.3.5 Europe Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.3.6 China Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.3.7 Japan Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Radiation Therapeutic Drugs
Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nuclear Radiation Therapeutic Drugs
Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nuclear Radiation Therapeutic Drugs
Demand (2018-2029)
2.2 World Nuclear Radiation Therapeutic Drugs
Consumption by Region
2.2.1 World Nuclear Radiation Therapeutic Drugs
Consumption by Region (2018-2023)
2.2.2 World Nuclear Radiation Therapeutic Drugs
Consumption Forecast by Region (2024-2029)
2.3 United States Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.4 China Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.5 Europe Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.6 Japan Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.7 South Korea Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.8 ASEAN Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.9 India Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
3 WORLD NUCLEAR RADIATION THERAPEUTIC DRUGS
Manufacturers Competitive Analysis
3.1 World Nuclear Radiation Therapeutic Drugs
Production Value by Manufacturer (2018-2023)
3.2 World Nuclear Radiation Therapeutic Drugs
Production by Manufacturer (2018-2023)
3.3 World Nuclear Radiation Therapeutic Drugs
Average Price by Manufacturer (2018-2023)
3.4 Nuclear Radiation Therapeutic Drugs
Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nuclear Radiation Therapeutic Drugs
Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nuclear Radiation Therapeutic Drugs
in 2022
3.5.3 Global Concentration Ratios (CR8) for Nuclear Radiation Therapeutic Drugs
in 2022
3.6 Nuclear Radiation Therapeutic Drugs
Market: Overall Company Footprint Analysis
3.6.1 Nuclear Radiation Therapeutic Drugs
Market: Region Footprint
3.6.2 Nuclear Radiation Therapeutic Drugs
Market: Company Product Type Footprint
3.6.3 Nuclear Radiation Therapeutic Drugs
Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Value Comparison
4.1.1 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Comparison
4.2.1 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nuclear Radiation Therapeutic Drugs
Consumption Comparison
4.3.1 United States VS China: Nuclear Radiation Therapeutic Drugs
Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nuclear Radiation Therapeutic Drugs
Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nuclear Radiation Therapeutic Drugs
Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023)
4.5 China Based Nuclear Radiation Therapeutic Drugs
Manufacturers and Market Share
4.5.1 China Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value (2018-2023)
4.5.3 China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023)
4.6 Rest of World Based Nuclear Radiation Therapeutic Drugs
Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Radiation Therapeutic Drugs
Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Diagnostic
5.2.2 Therapeutic
5.3 Market Segment by Type
5.3.1 World Nuclear Radiation Therapeutic Drugs
Production by Type (2018-2029)
5.3.2 World Nuclear Radiation Therapeutic Drugs
Production Value by Type (2018-2029)
5.3.3 World Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nuclear Radiation Therapeutic Drugs
Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Thyroid
6.2.3 Cardiology
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Nuclear Radiation Therapeutic Drugs
Production by Application (2018-2029)
6.3.2 World Nuclear Radiation Therapeutic Drugs
Production Value by Application (2018-2029)
6.3.3 World Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Nihon Medi-Physics Co.,Ltd.
7.1.1 Nihon Medi-Physics Co.,Ltd. Details
7.1.2 Nihon Medi-Physics Co.,Ltd. Major Business
7.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
7.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
7.1.6 Nihon Medi-Physics Co.,Ltd. Competitive Strengths & Weaknesses
7.2 Curium Pharma
7.2.1 Curium Pharma Details
7.2.2 Curium Pharma Major Business
7.2.3 Curium Pharma Nuclear Radiation Therapeutic Drugs
Product and Services
7.2.4 Curium Pharma Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Curium Pharma Recent Developments/Updates
7.2.6 Curium Pharma Competitive Strengths & Weaknesses
7.3 Cardinal Health
7.3.1 Cardinal Health Details
7.3.2 Cardinal Health Major Business
7.3.3 Cardinal Health Nuclear Radiation Therapeutic Drugs
Product and Services
7.3.4 Cardinal Health Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cardinal Health Recent Developments/Updates
7.3.6 Cardinal Health Competitive Strengths & Weaknesses
7.4 Bayer Global
7.4.1 Bayer Global Details
7.4.2 Bayer Global Major Business
7.4.3 Bayer Global Nuclear Radiation Therapeutic Drugs
Product and Services
7.4.4 Bayer Global Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer Global Recent Developments/Updates
7.4.6 Bayer Global Competitive Strengths & Weaknesses
7.5 GE Healthcare
7.5.1 GE Healthcare Details
7.5.2 GE Healthcare Major Business
7.5.3 GE Healthcare Nuclear Radiation Therapeutic Drugs
Product and Services
7.5.4 GE Healthcare Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GE Healthcare Recent Developments/Updates
7.5.6 GE Healthcare Competitive Strengths & Weaknesses
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Details
7.6.2 Mallinckrodt Pharmaceuticals Major Business
7.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Product and Services
7.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.6.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Bracco Group
7.7.1 Bracco Group Details
7.7.2 Bracco Group Major Business
7.7.3 Bracco Group Nuclear Radiation Therapeutic Drugs
Product and Services
7.7.4 Bracco Group Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bracco Group Recent Developments/Updates
7.7.6 Bracco Group Competitive Strengths & Weaknesses
7.8 Advanced Molecular-imaging Solution
7.8.1 Advanced Molecular-imaging Solution Details
7.8.2 Advanced Molecular-imaging Solution Major Business
7.8.3 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Product and Services
7.8.4 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Advanced Molecular-imaging Solution Recent Developments/Updates
7.8.6 Advanced Molecular-imaging Solution Competitive Strengths & Weaknesses
7.9 Ciaeriar
7.9.1 Ciaeriar Details
7.9.2 Ciaeriar Major Business
7.9.3 Ciaeriar Nuclear Radiation Therapeutic Drugs
Product and Services
7.9.4 Ciaeriar Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Ciaeriar Recent Developments/Updates
7.9.6 Ciaeriar Competitive Strengths & Weaknesses
7.10 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
7.10.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Details
7.10.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
7.10.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
7.10.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.10.6 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nuclear Radiation Therapeutic Drugs
Industry Chain
8.2 Nuclear Radiation Therapeutic Drugs
Upstream Analysis
8.2.1 Nuclear Radiation Therapeutic Drugs
Core Raw Materials
8.2.2 Main Manufacturers of Nuclear Radiation Therapeutic Drugs
Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nuclear Radiation Therapeutic Drugs
Production Mode
8.6 Nuclear Radiation Therapeutic Drugs
Procurement Model
8.7 Nuclear Radiation Therapeutic Drugs
Industry Sales Model and Sales Channels
8.7.1 Nuclear Radiation Therapeutic Drugs
Sales Model
8.7.2 Nuclear Radiation Therapeutic Drugs
Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Nuclear Radiation Therapeutic Drugs
Introduction
1.2 World Nuclear Radiation Therapeutic Drugs
Supply & Forecast
1.2.1 World Nuclear Radiation Therapeutic Drugs
Production Value (2018 & 2022 & 2029)
1.2.2 World Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.2.3 World Nuclear Radiation Therapeutic Drugs
Pricing Trends (2018-2029)
1.3 World Nuclear Radiation Therapeutic Drugs
Production by Region (Based on Production Site)
1.3.1 World Nuclear Radiation Therapeutic Drugs
Production Value by Region (2018-2029)
1.3.2 World Nuclear Radiation Therapeutic Drugs
Production by Region (2018-2029)
1.3.3 World Nuclear Radiation Therapeutic Drugs
Average Price by Region (2018-2029)
1.3.4 North America Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.3.5 Europe Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.3.6 China Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.3.7 Japan Nuclear Radiation Therapeutic Drugs
Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nuclear Radiation Therapeutic Drugs
Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nuclear Radiation Therapeutic Drugs
Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Nuclear Radiation Therapeutic Drugs
Demand (2018-2029)
2.2 World Nuclear Radiation Therapeutic Drugs
Consumption by Region
2.2.1 World Nuclear Radiation Therapeutic Drugs
Consumption by Region (2018-2023)
2.2.2 World Nuclear Radiation Therapeutic Drugs
Consumption Forecast by Region (2024-2029)
2.3 United States Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.4 China Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.5 Europe Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.6 Japan Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.7 South Korea Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.8 ASEAN Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
2.9 India Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029)
3 WORLD NUCLEAR RADIATION THERAPEUTIC DRUGS
Manufacturers Competitive Analysis
3.1 World Nuclear Radiation Therapeutic Drugs
Production Value by Manufacturer (2018-2023)
3.2 World Nuclear Radiation Therapeutic Drugs
Production by Manufacturer (2018-2023)
3.3 World Nuclear Radiation Therapeutic Drugs
Average Price by Manufacturer (2018-2023)
3.4 Nuclear Radiation Therapeutic Drugs
Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nuclear Radiation Therapeutic Drugs
Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nuclear Radiation Therapeutic Drugs
in 2022
3.5.3 Global Concentration Ratios (CR8) for Nuclear Radiation Therapeutic Drugs
in 2022
3.6 Nuclear Radiation Therapeutic Drugs
Market: Overall Company Footprint Analysis
3.6.1 Nuclear Radiation Therapeutic Drugs
Market: Region Footprint
3.6.2 Nuclear Radiation Therapeutic Drugs
Market: Company Product Type Footprint
3.6.3 Nuclear Radiation Therapeutic Drugs
Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Value Comparison
4.1.1 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Comparison
4.2.1 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nuclear Radiation Therapeutic Drugs
Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nuclear Radiation Therapeutic Drugs
Consumption Comparison
4.3.1 United States VS China: Nuclear Radiation Therapeutic Drugs
Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nuclear Radiation Therapeutic Drugs
Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nuclear Radiation Therapeutic Drugs
Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023)
4.5 China Based Nuclear Radiation Therapeutic Drugs
Manufacturers and Market Share
4.5.1 China Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value (2018-2023)
4.5.3 China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023)
4.6 Rest of World Based Nuclear Radiation Therapeutic Drugs
Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nuclear Radiation Therapeutic Drugs
Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Diagnostic
5.2.2 Therapeutic
5.3 Market Segment by Type
5.3.1 World Nuclear Radiation Therapeutic Drugs
Production by Type (2018-2029)
5.3.2 World Nuclear Radiation Therapeutic Drugs
Production Value by Type (2018-2029)
5.3.3 World Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nuclear Radiation Therapeutic Drugs
Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Thyroid
6.2.3 Cardiology
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Nuclear Radiation Therapeutic Drugs
Production by Application (2018-2029)
6.3.2 World Nuclear Radiation Therapeutic Drugs
Production Value by Application (2018-2029)
6.3.3 World Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Nihon Medi-Physics Co.,Ltd.
7.1.1 Nihon Medi-Physics Co.,Ltd. Details
7.1.2 Nihon Medi-Physics Co.,Ltd. Major Business
7.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
7.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
7.1.6 Nihon Medi-Physics Co.,Ltd. Competitive Strengths & Weaknesses
7.2 Curium Pharma
7.2.1 Curium Pharma Details
7.2.2 Curium Pharma Major Business
7.2.3 Curium Pharma Nuclear Radiation Therapeutic Drugs
Product and Services
7.2.4 Curium Pharma Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Curium Pharma Recent Developments/Updates
7.2.6 Curium Pharma Competitive Strengths & Weaknesses
7.3 Cardinal Health
7.3.1 Cardinal Health Details
7.3.2 Cardinal Health Major Business
7.3.3 Cardinal Health Nuclear Radiation Therapeutic Drugs
Product and Services
7.3.4 Cardinal Health Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cardinal Health Recent Developments/Updates
7.3.6 Cardinal Health Competitive Strengths & Weaknesses
7.4 Bayer Global
7.4.1 Bayer Global Details
7.4.2 Bayer Global Major Business
7.4.3 Bayer Global Nuclear Radiation Therapeutic Drugs
Product and Services
7.4.4 Bayer Global Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bayer Global Recent Developments/Updates
7.4.6 Bayer Global Competitive Strengths & Weaknesses
7.5 GE Healthcare
7.5.1 GE Healthcare Details
7.5.2 GE Healthcare Major Business
7.5.3 GE Healthcare Nuclear Radiation Therapeutic Drugs
Product and Services
7.5.4 GE Healthcare Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 GE Healthcare Recent Developments/Updates
7.5.6 GE Healthcare Competitive Strengths & Weaknesses
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Details
7.6.2 Mallinckrodt Pharmaceuticals Major Business
7.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Product and Services
7.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.6.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.7 Bracco Group
7.7.1 Bracco Group Details
7.7.2 Bracco Group Major Business
7.7.3 Bracco Group Nuclear Radiation Therapeutic Drugs
Product and Services
7.7.4 Bracco Group Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bracco Group Recent Developments/Updates
7.7.6 Bracco Group Competitive Strengths & Weaknesses
7.8 Advanced Molecular-imaging Solution
7.8.1 Advanced Molecular-imaging Solution Details
7.8.2 Advanced Molecular-imaging Solution Major Business
7.8.3 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Product and Services
7.8.4 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Advanced Molecular-imaging Solution Recent Developments/Updates
7.8.6 Advanced Molecular-imaging Solution Competitive Strengths & Weaknesses
7.9 Ciaeriar
7.9.1 Ciaeriar Details
7.9.2 Ciaeriar Major Business
7.9.3 Ciaeriar Nuclear Radiation Therapeutic Drugs
Product and Services
7.9.4 Ciaeriar Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Ciaeriar Recent Developments/Updates
7.9.6 Ciaeriar Competitive Strengths & Weaknesses
7.10 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
7.10.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Details
7.10.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
7.10.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
7.10.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.10.6 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nuclear Radiation Therapeutic Drugs
Industry Chain
8.2 Nuclear Radiation Therapeutic Drugs
Upstream Analysis
8.2.1 Nuclear Radiation Therapeutic Drugs
Core Raw Materials
8.2.2 Main Manufacturers of Nuclear Radiation Therapeutic Drugs
Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nuclear Radiation Therapeutic Drugs
Production Mode
8.6 Nuclear Radiation Therapeutic Drugs
Procurement Model
8.7 Nuclear Radiation Therapeutic Drugs
Industry Sales Model and Sales Channels
8.7.1 Nuclear Radiation Therapeutic Drugs
Sales Model
8.7.2 Nuclear Radiation Therapeutic Drugs
Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Nuclear Radiation Therapeutic Drugs
Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nuclear Radiation Therapeutic Drugs
Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nuclear Radiation Therapeutic Drugs
Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Region (2018-2023)
Table 5. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Region (2024-2029)
Table 6. World Nuclear Radiation Therapeutic Drugs
Production by Region (2018-2023) & (Units)
Table 7. World Nuclear Radiation Therapeutic Drugs
Production by Region (2024-2029) & (Units)
Table 8. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Region (2018-2023)
Table 9. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Region (2024-2029)
Table 10. World Nuclear Radiation Therapeutic Drugs
Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nuclear Radiation Therapeutic Drugs
Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nuclear Radiation Therapeutic Drugs
Major Market Trends
Table 13. World Nuclear Radiation Therapeutic Drugs
Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Nuclear Radiation Therapeutic Drugs
Consumption by Region (2018-2023) & (Units)
Table 15. World Nuclear Radiation Therapeutic Drugs
Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Nuclear Radiation Therapeutic Drugs
Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nuclear Radiation Therapeutic Drugs
Producers in 2022
Table 18. World Nuclear Radiation Therapeutic Drugs
Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Nuclear Radiation Therapeutic Drugs
Producers in 2022
Table 20. World Nuclear Radiation Therapeutic Drugs
Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nuclear Radiation Therapeutic Drugs
Company Evaluation Quadrant
Table 22. World Nuclear Radiation Therapeutic Drugs
Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nuclear Radiation Therapeutic Drugs
Production Site of Key Manufacturer
Table 24. Nuclear Radiation Therapeutic Drugs
Market: Company Product Type Footprint
Table 25. Nuclear Radiation Therapeutic Drugs
Market: Company Product Application Footprint
Table 26. Nuclear Radiation Therapeutic Drugs
Competitive Factors
Table 27. Nuclear Radiation Therapeutic Drugs
New Entrant and Capacity Expansion Plans
Table 28. Nuclear Radiation Therapeutic Drugs
Mergers & Acquisitions Activity
Table 29. United States VS China Nuclear Radiation Therapeutic Drugs
Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nuclear Radiation Therapeutic Drugs
Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Nuclear Radiation Therapeutic Drugs
Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share (2018-2023)
Table 37. China Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share (2018-2023)
Table 42. Rest of World Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share (2018-2023)
Table 47. World Nuclear Radiation Therapeutic Drugs
Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nuclear Radiation Therapeutic Drugs
Production by Type (2018-2023) & (Units)
Table 49. World Nuclear Radiation Therapeutic Drugs
Production by Type (2024-2029) & (Units)
Table 50. World Nuclear Radiation Therapeutic Drugs
Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nuclear Radiation Therapeutic Drugs
Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nuclear Radiation Therapeutic Drugs
Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nuclear Radiation Therapeutic Drugs
Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nuclear Radiation Therapeutic Drugs
Production by Application (2018-2023) & (Units)
Table 56. World Nuclear Radiation Therapeutic Drugs
Production by Application (2024-2029) & (Units)
Table 57. World Nuclear Radiation Therapeutic Drugs
Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nuclear Radiation Therapeutic Drugs
Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nuclear Radiation Therapeutic Drugs
Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Nihon Medi-Physics Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Nihon Medi-Physics Co.,Ltd. Major Business
Table 63. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
Table 64. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
Table 66. Nihon Medi-Physics Co.,Ltd. Competitive Strengths & Weaknesses
Table 67. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Curium Pharma Major Business
Table 69. Curium Pharma Nuclear Radiation Therapeutic Drugs
Product and Services
Table 70. Curium Pharma Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Curium Pharma Recent Developments/Updates
Table 72. Curium Pharma Competitive Strengths & Weaknesses
Table 73. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 74. Cardinal Health Major Business
Table 75. Cardinal Health Nuclear Radiation Therapeutic Drugs
Product and Services
Table 76. Cardinal Health Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cardinal Health Recent Developments/Updates
Table 78. Cardinal Health Competitive Strengths & Weaknesses
Table 79. Bayer Global Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Global Major Business
Table 81. Bayer Global Nuclear Radiation Therapeutic Drugs
Product and Services
Table 82. Bayer Global Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Global Recent Developments/Updates
Table 84. Bayer Global Competitive Strengths & Weaknesses
Table 85. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 86. GE Healthcare Major Business
Table 87. GE Healthcare Nuclear Radiation Therapeutic Drugs
Product and Services
Table 88. GE Healthcare Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GE Healthcare Recent Developments/Updates
Table 90. GE Healthcare Competitive Strengths & Weaknesses
Table 91. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Mallinckrodt Pharmaceuticals Major Business
Table 93. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Product and Services
Table 94. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 96. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Bracco Group Basic Information, Manufacturing Base and Competitors
Table 98. Bracco Group Major Business
Table 99. Bracco Group Nuclear Radiation Therapeutic Drugs
Product and Services
Table 100. Bracco Group Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bracco Group Recent Developments/Updates
Table 102. Bracco Group Competitive Strengths & Weaknesses
Table 103. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
Table 104. Advanced Molecular-imaging Solution Major Business
Table 105. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Product and Services
Table 106. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 108. Advanced Molecular-imaging Solution Competitive Strengths & Weaknesses
Table 109. Ciaeriar Basic Information, Manufacturing Base and Competitors
Table 110. Ciaeriar Major Business
Table 111. Ciaeriar Nuclear Radiation Therapeutic Drugs
Product and Services
Table 112. Ciaeriar Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Ciaeriar Recent Developments/Updates
Table 114. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 115. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
Table 116. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
Table 117. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Nuclear Radiation Therapeutic Drugs
Upstream (Raw Materials)
Table 119. Nuclear Radiation Therapeutic Drugs
Typical Customers
Table 120. Nuclear Radiation Therapeutic Drugs
Typical Distributors
Table 1. World Nuclear Radiation Therapeutic Drugs
Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nuclear Radiation Therapeutic Drugs
Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nuclear Radiation Therapeutic Drugs
Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Region (2018-2023)
Table 5. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Region (2024-2029)
Table 6. World Nuclear Radiation Therapeutic Drugs
Production by Region (2018-2023) & (Units)
Table 7. World Nuclear Radiation Therapeutic Drugs
Production by Region (2024-2029) & (Units)
Table 8. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Region (2018-2023)
Table 9. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Region (2024-2029)
Table 10. World Nuclear Radiation Therapeutic Drugs
Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nuclear Radiation Therapeutic Drugs
Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nuclear Radiation Therapeutic Drugs
Major Market Trends
Table 13. World Nuclear Radiation Therapeutic Drugs
Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Nuclear Radiation Therapeutic Drugs
Consumption by Region (2018-2023) & (Units)
Table 15. World Nuclear Radiation Therapeutic Drugs
Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Nuclear Radiation Therapeutic Drugs
Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nuclear Radiation Therapeutic Drugs
Producers in 2022
Table 18. World Nuclear Radiation Therapeutic Drugs
Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Nuclear Radiation Therapeutic Drugs
Producers in 2022
Table 20. World Nuclear Radiation Therapeutic Drugs
Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nuclear Radiation Therapeutic Drugs
Company Evaluation Quadrant
Table 22. World Nuclear Radiation Therapeutic Drugs
Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nuclear Radiation Therapeutic Drugs
Production Site of Key Manufacturer
Table 24. Nuclear Radiation Therapeutic Drugs
Market: Company Product Type Footprint
Table 25. Nuclear Radiation Therapeutic Drugs
Market: Company Product Application Footprint
Table 26. Nuclear Radiation Therapeutic Drugs
Competitive Factors
Table 27. Nuclear Radiation Therapeutic Drugs
New Entrant and Capacity Expansion Plans
Table 28. Nuclear Radiation Therapeutic Drugs
Mergers & Acquisitions Activity
Table 29. United States VS China Nuclear Radiation Therapeutic Drugs
Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nuclear Radiation Therapeutic Drugs
Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Nuclear Radiation Therapeutic Drugs
Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share (2018-2023)
Table 37. China Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share (2018-2023)
Table 42. Rest of World Based Nuclear Radiation Therapeutic Drugs
Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share (2018-2023)
Table 47. World Nuclear Radiation Therapeutic Drugs
Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nuclear Radiation Therapeutic Drugs
Production by Type (2018-2023) & (Units)
Table 49. World Nuclear Radiation Therapeutic Drugs
Production by Type (2024-2029) & (Units)
Table 50. World Nuclear Radiation Therapeutic Drugs
Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nuclear Radiation Therapeutic Drugs
Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nuclear Radiation Therapeutic Drugs
Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nuclear Radiation Therapeutic Drugs
Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nuclear Radiation Therapeutic Drugs
Production by Application (2018-2023) & (Units)
Table 56. World Nuclear Radiation Therapeutic Drugs
Production by Application (2024-2029) & (Units)
Table 57. World Nuclear Radiation Therapeutic Drugs
Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nuclear Radiation Therapeutic Drugs
Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nuclear Radiation Therapeutic Drugs
Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Nihon Medi-Physics Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Nihon Medi-Physics Co.,Ltd. Major Business
Table 63. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
Table 64. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Nihon Medi-Physics Co.,Ltd. Recent Developments/Updates
Table 66. Nihon Medi-Physics Co.,Ltd. Competitive Strengths & Weaknesses
Table 67. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Curium Pharma Major Business
Table 69. Curium Pharma Nuclear Radiation Therapeutic Drugs
Product and Services
Table 70. Curium Pharma Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Curium Pharma Recent Developments/Updates
Table 72. Curium Pharma Competitive Strengths & Weaknesses
Table 73. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 74. Cardinal Health Major Business
Table 75. Cardinal Health Nuclear Radiation Therapeutic Drugs
Product and Services
Table 76. Cardinal Health Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cardinal Health Recent Developments/Updates
Table 78. Cardinal Health Competitive Strengths & Weaknesses
Table 79. Bayer Global Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Global Major Business
Table 81. Bayer Global Nuclear Radiation Therapeutic Drugs
Product and Services
Table 82. Bayer Global Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Global Recent Developments/Updates
Table 84. Bayer Global Competitive Strengths & Weaknesses
Table 85. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 86. GE Healthcare Major Business
Table 87. GE Healthcare Nuclear Radiation Therapeutic Drugs
Product and Services
Table 88. GE Healthcare Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. GE Healthcare Recent Developments/Updates
Table 90. GE Healthcare Competitive Strengths & Weaknesses
Table 91. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Mallinckrodt Pharmaceuticals Major Business
Table 93. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Product and Services
Table 94. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 96. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 97. Bracco Group Basic Information, Manufacturing Base and Competitors
Table 98. Bracco Group Major Business
Table 99. Bracco Group Nuclear Radiation Therapeutic Drugs
Product and Services
Table 100. Bracco Group Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bracco Group Recent Developments/Updates
Table 102. Bracco Group Competitive Strengths & Weaknesses
Table 103. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors
Table 104. Advanced Molecular-imaging Solution Major Business
Table 105. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Product and Services
Table 106. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 108. Advanced Molecular-imaging Solution Competitive Strengths & Weaknesses
Table 109. Ciaeriar Basic Information, Manufacturing Base and Competitors
Table 110. Ciaeriar Major Business
Table 111. Ciaeriar Nuclear Radiation Therapeutic Drugs
Product and Services
Table 112. Ciaeriar Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Ciaeriar Recent Developments/Updates
Table 114. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 115. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Major Business
Table 116. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Product and Services
Table 117. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs
Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Nuclear Radiation Therapeutic Drugs
Upstream (Raw Materials)
Table 119. Nuclear Radiation Therapeutic Drugs
Typical Customers
Table 120. Nuclear Radiation Therapeutic Drugs
Typical Distributors
LIST OF FIGURES
Figure 1. Nuclear Radiation Therapeutic Drugs
Picture
Figure 2. World Nuclear Radiation Therapeutic Drugs
Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nuclear Radiation Therapeutic Drugs
Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 5. World Nuclear Radiation Therapeutic Drugs
Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Region (2018-2029)
Figure 7. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Region (2018-2029)
Figure 8. North America Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 9. Europe Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 10. China Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 11. Japan Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 12. Nuclear Radiation Therapeutic Drugs
Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 15. World Nuclear Radiation Therapeutic Drugs
Consumption Market Share by Region (2018-2029)
Figure 16. United States Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 17. China Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 18. Europe Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 19. Japan Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 20. South Korea Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 21. ASEAN Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 22. India Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Nuclear Radiation Therapeutic Drugs
by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nuclear Radiation Therapeutic Drugs
Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nuclear Radiation Therapeutic Drugs
Markets in 2022
Figure 26. United States VS China: Nuclear Radiation Therapeutic Drugs
Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nuclear Radiation Therapeutic Drugs
Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nuclear Radiation Therapeutic Drugs
Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share 2022
Figure 30. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share 2022
Figure 32. World Nuclear Radiation Therapeutic Drugs
Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Type in 2022
Figure 34. Diagnostic
Figure 35. Therapeutic
Figure 36. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Type (2018-2029)
Figure 37. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Type (2018-2029)
Figure 38. World Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Nuclear Radiation Therapeutic Drugs
Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Application in 2022
Figure 41. Oncology
Figure 42. Thyroid
Figure 43. Cardiology
Figure 44. Others
Figure 45. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Application (2018-2029)
Figure 46. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Application (2018-2029)
Figure 47. World Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Nuclear Radiation Therapeutic Drugs
Industry Chain
Figure 49. Nuclear Radiation Therapeutic Drugs
Procurement Model
Figure 50. Nuclear Radiation Therapeutic Drugs
Sales Model
Figure 51. Nuclear Radiation Therapeutic Drugs
Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Nuclear Radiation Therapeutic Drugs
Picture
Figure 2. World Nuclear Radiation Therapeutic Drugs
Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nuclear Radiation Therapeutic Drugs
Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 5. World Nuclear Radiation Therapeutic Drugs
Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Region (2018-2029)
Figure 7. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Region (2018-2029)
Figure 8. North America Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 9. Europe Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 10. China Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 11. Japan Nuclear Radiation Therapeutic Drugs
Production (2018-2029) & (Units)
Figure 12. Nuclear Radiation Therapeutic Drugs
Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 15. World Nuclear Radiation Therapeutic Drugs
Consumption Market Share by Region (2018-2029)
Figure 16. United States Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 17. China Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 18. Europe Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 19. Japan Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 20. South Korea Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 21. ASEAN Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 22. India Nuclear Radiation Therapeutic Drugs
Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Nuclear Radiation Therapeutic Drugs
by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nuclear Radiation Therapeutic Drugs
Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nuclear Radiation Therapeutic Drugs
Markets in 2022
Figure 26. United States VS China: Nuclear Radiation Therapeutic Drugs
Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nuclear Radiation Therapeutic Drugs
Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nuclear Radiation Therapeutic Drugs
Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share 2022
Figure 30. China Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nuclear Radiation Therapeutic Drugs
Production Market Share 2022
Figure 32. World Nuclear Radiation Therapeutic Drugs
Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Type in 2022
Figure 34. Diagnostic
Figure 35. Therapeutic
Figure 36. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Type (2018-2029)
Figure 37. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Type (2018-2029)
Figure 38. World Nuclear Radiation Therapeutic Drugs
Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Nuclear Radiation Therapeutic Drugs
Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Application in 2022
Figure 41. Oncology
Figure 42. Thyroid
Figure 43. Cardiology
Figure 44. Others
Figure 45. World Nuclear Radiation Therapeutic Drugs
Production Market Share by Application (2018-2029)
Figure 46. World Nuclear Radiation Therapeutic Drugs
Production Value Market Share by Application (2018-2029)
Figure 47. World Nuclear Radiation Therapeutic Drugs
Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Nuclear Radiation Therapeutic Drugs
Industry Chain
Figure 49. Nuclear Radiation Therapeutic Drugs
Procurement Model
Figure 50. Nuclear Radiation Therapeutic Drugs
Sales Model
Figure 51. Nuclear Radiation Therapeutic Drugs
Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
